Methods And Compositions For Treating Symptoms Associated With Post-Traumatic Stress Disorder Using Cyclobenzaprine

Patent No. EP2501234 (titled "Methods And Compositions For Treating Symptoms Associated With Post-Traumatic Stress Disorder Using Cyclobenzaprine") was filed by Tonix Pharma on Nov 16, 2010. The application was issued on Sep 13, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LEDERER & KELLERJun 13, 2018BEST
KRAUS & LEDERER PARTGMBBJun 13, 2018KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2501234

TONIX PHARMA
Application Number
EP10831895A
Filing Date
Nov 16, 2010
Status
Revoked
Mar 26, 2024
Publication Date
Sep 13, 2017